We are live on ! Find out more
TOVX icon

Theriva Biologics

17 hedge funds and large institutions have $830K invested in Theriva Biologics in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.24% less ownership

Funds ownership: 11.01% → 9.77% (-1.2%)

15% less funds holding

Funds holding: 20 → 17 (-3)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

66% less capital inflows, than outflows

Capital inflows: $46.6K | Capital outflows: $138K

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
4
Calls
$2.65​M
Puts
–
Net Calls
+$2.65​M
Net Calls Change
+$278​K

TOVX Hedge Fund Activity: Q4 2019 in Review

17 of the 5,095 institutional investors tracked by Wall St. Rank reported a position in Theriva Biologics (TOVX) for Q4 2019, worth a combined $830K — down 0.66% from $836K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TOVX and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $34.2K. The largest seller was Sabby Management, cutting an estimated $63.1K.

  • 17 institutional investors held Theriva Biologics (TOVX) as of Q4 2019, down from 20 in Q3 2019.
  • Funds reported $830K of Theriva Biologics stock for Q4 2019, down 0.66% quarter-over-quarter.
  • 1 fund opened new Theriva Biologics positions in Q4 2019 and 4 closed out, a net change of -3 holders.
  • The largest Theriva Biologics buyer in Q4 2019 was Renaissance Technologies, an estimated $34.2K added.
  • The largest Theriva Biologics seller in Q4 2019 was Sabby Management, an estimated $63.1K sold.

Based on aggregated 13F filings for Q4 2019.